Searchable abstracts of presentations at key conferences in endocrinology

ea0094p182 | Adrenal and Cardiovascular | SFEBES2023

Clinical challenges in the biochemical evaluation of Pheochromocytoma: A case report of pseudo-pheochromocytoma in a patient with Obstructive Sleep Apnoea(OSA)

Nijith Lakshmi , Thong Lim Chung , Banerjee Ritwik

The diagnosis of Pheochromocytomas often poses a great challenge. We report a case of pseudo-pheochromocytoma causing challenges in the clinical diagnosis. A 35-year old gentleman with high BMI, was admitted with worsening headache, visual field defects and accelerated hypertension. MRI pituitary and biochemical profiling revealed a non-functioning pituitary macroadenoma with optic chiasm compression, warranting urgent surgical intervention, vindicating an endocrinology referr...

ea0094p229 | Metabolism, Obesity and Diabetes | SFEBES2023

A Case report of the rare non-diabetic euglycaemic ketoacidosis (NDEK) in patient with acute pancreatitis

Chan Sigmund , Nijith Lakshmi , Thong Lim Chung

Non-diabetic euglycaemic ketoacidosis (NDEK) is a rare condition defined as euglycaemia, metabolic acidosis and elevated serum ketones occurring in patients without diabetes mellitus. It is less well known compared to diabetic ketoacidosis (DKA) and euglycaemic diabetic ketoacidosis (EDKA), both happening in patients with diabetes. Here we describe a case of a 35-year old woman, previously fit and well, who presented with unidentified cause of pancreatitis leading to severe me...

ea0091p44 | Poster Presentations | SFEEU2023

Challenges in the management of chronic hypoparathyroidism and severe hypocalcaemia in post thyroidectomy- is there a rationale in using recombinant human parathyroid hormone?

Nijith Lakshmi , Chan Sigmond , Ward Lisa , Bottoms Nicole , Banerjee Ritwik

39-year-old female, with a past medical history of Graves Hyperthyroidism, underwent total thyroidectomy 18 years ago, with resultant hypoparathyroidism, hypocalcaemia and hypothyroidism. Her calcium levels are usually in the range of 1.6-1.8 mmol/l, but there are times when it can go to dangerously low levels (range of 1.4-1.15 mmol/l) causing symptoms, sometimes with ECG changes, requiring hospital admissions and IV calcium replacements. There is no parathyroid activity dete...

ea0086cc7 | Featured Clinical Case Posters | SFEBES2022

Cholestyramine as monotherapy for thyrotoxicosis: experience at a tertiary care centre during COVID-19 pandemic

Iqbal Fizzah , Yin Win , Nijith Lakshmi , Lansdown Andrew , Taylor Peter , Witczak Justyna

Introduction: Thionamides are the mainstay of management of thyrotoxicosis but can be associated with adverse effects like agranulocystosis, hepatitis and vasculitis. While radioactive iodine and thyroidectomy can be utilized in such scenarios, they were not timely available during the COVID pandemic. We present our experience of using cholestyramine as monotherapy.Case Series: Our series consists of four females. GravesÂ’ disease was the underlying ...

ea0094p77 | Metabolism, Obesity and Diabetes | SFEBES2023

A retrospective audit on the adherence of Trust guidelines in the management of Hyponatremia at a DGH

Khan Hashim , Nijith Lakshmi , Thulaseedharan Pillai Rakesh , Abdalaziz Mohamed , Benny Archana , Thayaparan Kunaratnam

Background: Hyponatremia is the most common electrolyte disorder encountered in clinical practice. Vulnerable cohorts tend to be hospitalised patients where it tends to occur in 15-20% of the patients and the other category being nursing home residents. Significant risk factors are increasing age, and polypharmacy.Aims: We aimed to look at the management of hyponatremia at our hospital, check adherence with the trust gui...